Missouri S&T Scholar's Mine Research RepositoryMissouri S&T Research
print 
Title: Oxidative stress in diabetes and alzheimer’s disease
Author (s): Reddy, Prakash
Zhu, Xiongwei
Perry, George
Smith, Mark A.
Department/Lab Affiliations: Center for Environmental Science and Technology (CEST)
Chemistry
Keywords: AGE inhibitors
advanced glycation end products
glycation
protein crosslinks
Subject Terms: Alzheimer's disease.
Diabetes.
Glycosylation.
Maillard reaction.
Oxidative stress.
Issue Date: 2009
Publisher: IOS Press
Citation: Reddy, V. Prakash, Xiongwei Zhu, George Perry, and Mark A. Smith. “Oxidative Stress in Diabetes and Alzheimer’s Disease”, Journal of Alzheimer's Disease, Vol. 16, No. 4, (2009): 763-774.
Abstract: Oxidative stress plays a major role in diabetes as well as in Alzheimer's disease and other related neurological diseases. Intracellular oxidative stress arises due to the imbalance in the production of reactive oxygen/reactive nitrogen species and cellular antioxidant defense mechanisms. In turn, the excess reactive oxygen/reactive nitrogen species mediate the damage of proteins and nucleic acids, which have been shown to have direct and deleterious consequences in diabetes and Alzheimer's disease. Oxidative stress also contributes to the production of advanced glycation end products through glycoxidation and lipid peroxidation. The advanced glycation end products and lipid peroxidation products are ubiquitous to diabetes and Alzheimer's disease and serve as markers of disease progression in both disorders. Antioxidants and advanced glycation end products inhibitors, either induced endogenously or exogenously introduced, may counteract with the deleterious effects of the reactive oxygen/reactive nitrogen species and thereby, in prevention or treatment paradigms, attenuate or substantially delay the onset of these devastating pathologies.
Type: Article - Journal
text
In Title: Journal of Alzheimer's Disease
Copyright Notice: This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.
Pre-print: author can archive; Post-print: author can archive;
FULL COPYRIGHT INFORMATION:
http://www.iospress.nl/
Publisher URL:
http://dx.doi.org/10.3233/JAD-2009-1013
Link to this page:
http://scholarsmine.mst.edu/post_prints/OxidativeStressInDiabetesAndAlzheimersDisease_09007dcc806da207.html



titleOxidative stress in diabetes and alzheimer’s disease
contributor.authorReddy, Prakash
contributor.authorZhu, Xiongwei
contributor.authorPerry, George
contributor.authorSmith, Mark A.
contributor.deptlabCenter for Environmental Science and Technology (CEST)
contributor.deptlabChemistry
subjectAGE inhibitors
subjectadvanced glycation end products
subjectglycation
subjectprotein crosslinks
subject.LCSHAlzheimer's disease.
subject.LCSHDiabetes.
subject.LCSHGlycosylation.
subject.LCSHMaillard reaction.
subject.LCSHOxidative stress.
date.issued2009
publisherIOS Press
identifier.citationReddy, V. Prakash, Xiongwei Zhu, George Perry, and Mark A. Smith. “Oxidative Stress in Diabetes and Alzheimer’s Disease”, Journal of Alzheimer's Disease, Vol. 16, No. 4, (2009): 763-774.
identifier.pub.URI
http://dx.doi.org/10.3233/JAD-2009-1013
description.abstractOxidative stress plays a major role in diabetes as well as in Alzheimer's disease and other related neurological diseases. Intracellular oxidative stress arises due to the imbalance in the production of reactive oxygen/reactive nitrogen species and cellular antioxidant defense mechanisms. In turn, the excess reactive oxygen/reactive nitrogen species mediate the damage of proteins and nucleic acids, which have been shown to have direct and deleterious consequences in diabetes and Alzheimer's disease. Oxidative stress also contributes to the production of advanced glycation end products through glycoxidation and lipid peroxidation. The advanced glycation end products and lipid peroxidation products are ubiquitous to diabetes and Alzheimer's disease and serve as markers of disease progression in both disorders. Antioxidants and advanced glycation end products inhibitors, either induced endogenously or exogenously introduced, may counteract with the deleterious effects of the reactive oxygen/reactive nitrogen species and thereby, in prevention or treatment paradigms, attenuate or substantially delay the onset of these devastating pathologies.
typeArticle - Journal
type.DCMITypetext
type.statusPostprint
relation.isPartOfJournal of Alzheimer's Disease
rightsThis material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All persons copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.
rightsPre-print: author can archive; Post-print: author can archive;
rights.URI
http://www.iospress.nl/
identifier.persist.URI
http://scholarsmine.mst.edu/post_prints/OxidativeStressInDiabetesAndAlzheimersDisease_09007dcc806da207.html
date.available2009-09-18T19:14:14Z